Institutional Review Board for Health Sciences Research (IRB-HSR)

Managing Protocol After Initial Approval

Post Approval Monitoring


The Post Approval Monitoring and Education program has three goals:

Post-approval monitoring is done by staff within the office of the Vice President for Research (VPR) in accordance with their Standard Operating Procedures.

The VPR Post Approval Monitor(s) will attend IRB meetings to provide feedback to the IRB members.

The reason(s) for on-site review may include:

Consent Observation

There may be times when a research study is viewed as sensitive or particularly risky or when for other reasons, the board has concerns regarding the process for obtaining informed consent. In these cases, the IRB-HSR may request Consent observation. Consent observation may be requested for one or more subjects.

Consent observation is performed by the Post-Approval Monitoring personnel. The IRB-HSR will inform the study team that consent observation is required. It is the responsibility of the study team to coordinate consent observation with the Post Approval Monitoring personnel. The Post Approval Monitoring personnel provide documentation of consent observations.

Post Approval Monitoring Process

The conduct of an on-site review may include but is not limited to:

Post Approval Monitoring Working Group

IRB Post Approval Monitoring Advisory Committee

The IRB-HSR PAM Advisory Committee will include no more than 6 members and will be chaired by the IRB-HSR chair. Members of the IRB-HSR will be invited to serve on the PAM Advisory Committee by the IRB-HSR chair. The members will serve on the committee for a two year term. Additional terms may be allowed at the discretion of the IRB-HSR Chair. Members will include at least one of each of the following individuals from the membership of the IRB-HSR:

The following individuals may also attend the meeting as non-voting members:

The meeting may be held in person or by conference call.

The post-approval compliance monitors from the Office of the Vice President for Research will conduct post-approval monitoring reviews. The procedures for doing post-approval monitoring are outlined in VPR PAM SOPS #1-1 to #1-8.

Aggregate results of the post-approval monitoring visits will be reported every 6 months by the post-approval monitors to the IRB-HSR members.

On a monthly basis the post approval monitors will send a detailed report of the audits conducted during the previous month to the members of the IRB-HSR Post Approval Monitoring (PAM) Advisory Committee.

The IRB-HSR PAM Advisory Committee acts as an advisory board to the IRB Chair as he/she makes determinations regarding compliance issues. The issues raised may come from PAM audits or other sources. The IRB-HSR PAM Advisory Committee may consult with outside specialists as deemed necessary.

If there are concerns regarding scientific misconduct such as fraud or IRS issues, notify the UVA Research Integrity Officer at 434-924-3606.

Non-Compliance: Auditing for Cause

Information regarding non-compliance in human subjects studies may come to the attention of the IRB in several ways.

These include:

The chair of the appropriate IRB reviews allegations of non-compliance.

The chair makes a determination as to whether the alleged practices appear to

In such cases, the chair may suspend the study procedures pending a timely investigation and review by the full IRB.

At the discretion of the chair or board, a study may continue while minor incidents of noncompliance are under investigation. The chair may elect to discuss an allegation of noncompliance with the IRB prior to suspending the protocol if it is apparent that there is no increased risk to subjects.

The Chair and/or the AVPR, may suspend studies when:

The chair and/or the IRB will confirm this action as soon as possible.

Allegations of Misconduct

Investigations by the IRB focus on the protection of study subjects. In cases that involve allegations of research misconduct, the chair contacts the University of Virginia Research Integrity Officer (RIO) for further action. This does not preclude the chair or any member of the IRB from independently contacting the RIO about any allegation of research misconduct. Inquiries or investigations into research misconduct do not preclude IRB review and actions.